Detalles de la búsqueda
1.
[Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the 2019 ASCO Meeting]. / Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs : Highlights des ASCO-Meetings 2019.
HNO;
67(12): 898-904, 2019 Dec.
Artículo
en Alemán
| MEDLINE | ID: mdl-31701170
2.
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).
Ann Oncol;
25(3): 682-688, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24567516
3.
[Therapy of recurrent or metastatic head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014]. / Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs : Highlights des ASCO-Meetings 2014.
HNO;
62(11): 787-92, 2014 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-25298331
4.
[The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013]. / Die wichtigsten Studienergebnisse der primären Radio-Chemo-Therapie von Kopf-Hals-Tumoren : Highlights des ASCO-Meetings 2013.
HNO;
61(11): 905-10, 2013 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-24221218
5.
[Therapy of recurrent and metastatic squamous cell carcinoma of the head and neck : highlights of the ASCO Meeting 2013]. / Therapie der Rezidiv- und Fernmetastasen bei Plattenepithelkarzinomen des Kopf- und Halsbereichs : Highlights des ASCO-Meetings 2013.
HNO;
61(11): 911-3, 2013 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-24221219
6.
Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach-Feasibility, safety and retrospective survival analysis in twenty-three patients.
Clin Otolaryngol;
42(6): 1392-1396, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28429525
7.
[The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting]. / Die wichtigsten Studienergebnisse der primären Radiochemotherapie von Kopf-Hals-Tumoren: Highlights vom ASCO-Meeting 2012.
HNO;
60(11): 962-7, 2012 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-23114542
8.
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.
ESMO Open;
6(5): 100242, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34482179
9.
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.
Leukemia;
34(7): 1775-1786, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31925317
10.
Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards.
Clin Microbiol Infect;
25(8): 1013-1020, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30641228
11.
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.
Leukemia;
31(4): 889-895, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27774990
12.
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach.
Leukemia;
14(10): 1850-6, 2000 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-11021760
13.
The current role of systemic chemotherapy in the primary treatment of head and neck cancer.
Cancer Treat Rev;
41(3): 217-21, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25687982
14.
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
Bone Marrow Transplant;
34(11): 955-62, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15489865
15.
Evaluation of BM cytomorphology after allo-SCT in patients with AML.
Bone Marrow Transplant;
47(12): 1538-44, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22543745
16.
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5).
Leukemia;
30(7): 1580-2, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26668126
17.
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS).
Leukemia;
30(9): 1956-9, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27133825
18.
[Induction chemotherapy in locally advanced head and neck cancer? Yes]. / Induktionschemotherapie bei lokal fortgeschrittenen Kopf-Hals-Karzinomen--pro.
Dtsch Med Wochenschr;
139(41): 2080, 2014 Oct.
Artículo
en Alemán
| MEDLINE | ID: mdl-25268208
19.
Evaluation of BM cytomorphology after allo-SCT in patients with MDS.
Bone Marrow Transplant;
48(3): 465-6, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22941378
20.
Semiquantitative reverse transcription polymerase chain reaction analysis for detection of bcr/abl rearrangement using RNA extracts from bone marrow aspirates compared with glass slide smears after 0, 2 and 4 d of storage.
Br J Haematol;
115(3): 583-7, 2001 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-11736939